Mirae Asset Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
LG
Mirae Asset Global Investments's AMPH Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Amphastar Pharmaceuticals (AMPH) stake by 17% in Q2 2026, selling an estimated $7.95K and leaving 1,972 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1393.
Mirae Asset Global Investments first reported a position in AMPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.14M in Q4 2023. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Mirae Asset Global Investments held 1,972 shares of Amphastar Pharmaceuticals worth $39.8K as of Q2 2026.
- Mirae Asset Global Investments sold 394 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $7.95K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1393 holding.
- Mirae Asset Global Investments first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Amphastar Pharmaceuticals position peaked at $1.14M in Q4 2023.
- 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.